Publication | Open Access

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial

VaccinationVaccine SafetyVaccine DevelopmentVaccine TargetImmunologyVaccine EfficacyHeterologous Boost ImmunisationChinese AdultsInactivated Sars-cov-2 VaccineMedicineCovid-19